J.W. Cole Advisors Inc. Has $377,000 Stock Position in The Clorox Company (NYSE:CLX)

J.W. Cole Advisors Inc. increased its stake in shares of The Clorox Company (NYSE:CLX) by 56.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,645 shares of the company’s stock after acquiring an additional 952 shares during the quarter. J.W. Cole Advisors Inc.’s holdings in Clorox were worth $377,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Investors Asset Management of Georgia Inc. GA ADV increased its position in Clorox by 6.6% during the fourth quarter. Investors Asset Management of Georgia Inc. GA ADV now owns 4,827 shares of the company’s stock worth $692,000 after acquiring an additional 300 shares during the period. Federated Hermes Inc. increased its position in Clorox by 483.8% during the fourth quarter. Federated Hermes Inc. now owns 27,696 shares of the company’s stock worth $3,949,000 after acquiring an additional 22,952 shares during the period. Livforsakringsbolaget Skandia Omsesidigt increased its holdings in Clorox by 106.6% in the 4th quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 312 shares of the company’s stock valued at $44,000 after buying an additional 161 shares during the period. Daiwa Securities Group Inc. increased its holdings in Clorox by 11.0% in the 4th quarter. Daiwa Securities Group Inc. now owns 11,449 shares of the company’s stock valued at $1,633,000 after buying an additional 1,139 shares during the period. Finally, Slow Capital Inc. increased its holdings in Clorox by 6.7% in the 4th quarter. Slow Capital Inc. now owns 15,597 shares of the company’s stock valued at $2,224,000 after buying an additional 976 shares during the period. Institutional investors own 78.53% of the company’s stock.

Clorox Stock Up 1.2 %

Shares of NYSE CLX opened at $147.79 on Thursday. The firm’s 50-day simple moving average is $149.59 and its 200 day simple moving average is $142.27. The company has a market cap of $18.34 billion, a price-to-earnings ratio of 234.59, a price-to-earnings-growth ratio of 2.29 and a beta of 0.43. The company has a quick ratio of 0.57, a current ratio of 0.89 and a debt-to-equity ratio of 11.37. The Clorox Company has a 12-month low of $114.68 and a 12-month high of $178.21.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Thursday, February 1st. The company reported $2.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.08 by $1.08. The business had revenue of $1.99 billion for the quarter, compared to the consensus estimate of $1.80 billion. Clorox had a net margin of 1.09% and a return on equity of 319.41%. The firm’s quarterly revenue was up 16.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.98 EPS. On average, research analysts expect that The Clorox Company will post 5.52 earnings per share for the current fiscal year.

Clorox Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 10th. Shareholders of record on Wednesday, April 24th will be given a dividend of $1.20 per share. The ex-dividend date of this dividend is Tuesday, April 23rd. This represents a $4.80 dividend on an annualized basis and a yield of 3.25%. Clorox’s payout ratio is presently 761.90%.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on CLX shares. Barclays lowered their price target on shares of Clorox from $148.00 to $136.00 and set an “underweight” rating on the stock in a report on Wednesday, April 10th. Jefferies Financial Group raised shares of Clorox from an “underperform” rating to a “hold” rating and set a $145.00 price target on the stock in a report on Tuesday, March 26th. JPMorgan Chase & Co. boosted their price target on shares of Clorox from $145.00 to $152.00 and gave the company a “neutral” rating in a report on Thursday, January 18th. UBS Group boosted their price target on shares of Clorox from $145.00 to $170.00 and gave the company a “neutral” rating in a report on Friday, February 2nd. Finally, DA Davidson reissued a “neutral” rating and issued a $162.00 price target on shares of Clorox in a report on Wednesday, April 17th. Four research analysts have rated the stock with a sell rating and thirteen have issued a hold rating to the company’s stock. According to MarketBeat.com, Clorox currently has a consensus rating of “Hold” and an average target price of $148.63.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.